24-24 April 2023
keyboard_arrow_left See all news

Recent News

17 Nov, 2022 /
PTI Engineered Plastics, Inc.
PTI Engineered Plastics Receives MedAccred® Plastics Continuing Accreditation
PTI Engineered Plastics recognized for its commitment to continual improvement in medica...
10 Nov, 2022 /
Donatelle significantly expands footprint and capacity for clean room assembly of high-volume medical device assembly
Donatelle announces the recent expansion of its ISO 7 (class 10,000) clean room capabil...
08 Nov, 2022 /
Husky Injection Molding Systems
Husky exhibits at Gulfood Manufacturing – showcases complete technologies, solutions and services to enable regional packaging producers
Husky Technologies is exhibiting at Gulfood Manufacturing 2022 in Dubai, UAE from Novemb...
03 Nov, 2022 /
Secant Group, LLC
Solesis Expands Film & Coating Capabilities with Acquisition of Polyzen
Solesis, parent company of Secant Group, acquires Polyzen to expand advanced biomaterial...
10 Oct, 2022 /
Minnesota Rubber & Plastics
Pushing Design Boundaries with Materials Science to Respond to the Voice of the Patient
The wearable drug delivery industry continues to expand, driving demand for smaller devi...
Toray Industries, Inc.
/ 22 Oct, 2020
keyboard_arrow_left See all news

TOYOLAC® Transparent ABS Medical Resin Finds Success With HEM's And Ventilator Components – Providing Enhanced Operating Performance In Covid-19 Treatment Devices

New York, NY:  Toyolac®'s lower molding temperatures and lower pressure requirements compared to other resin materials is proving to help increase production capacity and turnaround time for Covid-19 related medical components. With operating cylinder temperatures ranging from 210°C to 260°C, Toyolac® provides smoother resin flow, increased cycle times with decreased part flash. This enhanced flowability provides increased part cavitation while providing better molding of thin-walled part features with less tooling wear and longer mold life.
Case-in-point: Heat and Moisture Exchangers components molded with Toyolac® resin meet multiple component assembly requirements, are easily bonded together with adhesives, providing a secure, long-lasting product. With robust resistance to lipids, alcohol and cleaning agents, Toyolac® produced HMEs provide ideal molded part designs. Toyolac® material structural also creates strength and stiffness across the molded components and is scratch resistant. The molded surface is also printable for tracking and identification purposes as well as brand identification.


Toyolac® has a stable quality and enables long-term adoption because of Toray's no change “Production Methods”, no change “Formulations” and no change “Test Methods/Equipment” policy ensuring long term stability for manufacturers and regulatory requirements. Toyolac® is a well-balanced resin and a FDA Drug Master File registered material.  It is USP Class 6 tested and meets ISO 10993 for biocompatibility. Specific tests include -4 for blood interactions, -5 for in vitro cytoxicity, -10 for irritation and skin sensitization and -11 for systemic cytotoxicity. (Toyolac® does not contain bisphenol-A, an industrial chemical commonly used to make plastics which through exposure can cause health problems.)

Toyolac® ABS Resin is proven for medical applications in liquid-contact devices other than implants. Toyolac®'s manufacturer, Toray, was the first manufacturer and is the world's largest manufacturer of transparent ABS resin.  Toray is a global leader in polymer chemistry, organic synthetic chemistry and biotechnology. The company now provides sales to North American medical OEM's along with expert customer support for improved HME product development and manufacturing.

For more information about TOYOLAC® Transparent ABS Resin, call 612-979-0613 to learn more. Or Email: [email protected]   www.toray.us  Toray Industries, Inc., 461 Fifth Ave, 9th Fl., New York NY 10017

About Toray
Toray Industries, Inc., is a world class, global, integrated, chemical industry group with businesses in 26 countries and markets worldwide. In 2018, Toray's sales exceeded $22 Billion and employed over 45,000 people worldwide. Toray combines nanotechnology with its core technologies of organic synthetic chemistry, polymer chemistry and biotechnology. These advanced basic materials technologies are applied to develop products in the chemicals, plastics, films, fibers, textiles, composites, pharmaceuticals and medical market segments. Toray's "Innovation by Chemistry" is applied in the medical market to create unique materials that benefit cutting edge products and provide more effective treatments at lower cost and less risk than current products.
Maintenance is currently underway as of 23:00 GMT Saturday 10 December. Any account information edits will not be saved. during this time. Please refrain from using favouriting and meeting functions during this time as this information will not be saved. The upgrade is expected to finish by 03:00 GMT Sunday 11 December.
Processing. Please wait.